Neurogene Inc (NGNE)
36.42
+1.60
(+4.60%)
USD |
NASDAQ |
Jun 28, 16:00
36.40
-0.02
(-0.05%)
After-Hours: 20:00
Neurogene Market Cap: 472.74M for June 28, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| June 28, 2024 | 472.74M |
| June 27, 2024 | 451.97M |
| June 26, 2024 | 415.50M |
| June 25, 2024 | 403.69M |
| June 24, 2024 | 412.12M |
| June 21, 2024 | 402.52M |
| June 20, 2024 | 403.30M |
| June 18, 2024 | 393.56M |
| June 17, 2024 | 519.21M |
| June 14, 2024 | 552.83M |
| June 13, 2024 | 545.04M |
| June 12, 2024 | 482.61M |
| June 11, 2024 | 482.61M |
| June 10, 2024 | 484.81M |
| June 07, 2024 | 491.69M |
| June 06, 2024 | 482.35M |
| June 05, 2024 | 486.37M |
| June 04, 2024 | 489.75M |
| June 03, 2024 | 483.26M |
| May 31, 2024 | 488.06M |
| May 30, 2024 | 441.72M |
| May 29, 2024 | 432.76M |
| May 28, 2024 | 411.61M |
| May 24, 2024 | 416.80M |
| May 23, 2024 | 408.75M |
| Date | Value |
|---|---|
| May 22, 2024 | 420.56M |
| May 21, 2024 | 422.12M |
| May 20, 2024 | 441.46M |
| May 17, 2024 | 432.37M |
| May 16, 2024 | 437.70M |
| May 15, 2024 | 436.01M |
| May 14, 2024 | 409.53M |
| May 13, 2024 | 397.72M |
| May 10, 2024 | 421.86M |
| May 09, 2024 | 431.08M |
| May 08, 2024 | 427.05M |
| May 07, 2024 | 440.55M |
| May 06, 2024 | 425.88M |
| May 03, 2024 | 471.27M |
| May 02, 2024 | 455.32M |
| May 01, 2024 | 434.47M |
| April 30, 2024 | 443.61M |
| April 29, 2024 | 429.71M |
| April 26, 2024 | 385.46M |
| April 25, 2024 | 384.30M |
| April 24, 2024 | 388.93M |
| April 23, 2024 | 401.02M |
| April 22, 2024 | 393.82M |
| April 19, 2024 | 392.28M |
| April 18, 2024 | 406.30M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
182.74M
Minimum
Dec 20 2023
654.22M
Maximum
Mar 28 2024
428.15M
Average
415.75M
Median
Market Cap Benchmarks
| Taysha Gene Therapies Inc | 415.18M |
| CEL-SCI Corp | 62.83M |
| AIM ImmunoTech Inc | 19.11M |
| IGC Pharma Inc | 32.81M |
| NovaBay Pharmaceuticals Inc | 2.389M |
Market Cap Related Metrics
| Price to Book Value | 2.768 |
| Price | 36.42 |
| Earnings Yield | -74.76% |